deltatrials
Completed NCT00125697

Characterization of Serial Magnetic Resonance Spectroscopy Imaging in Patients With Malignant Glioma Undergoing Radiotherapy

Sponsor: AHS Cancer Control Alberta

Conditions Malignant Glioma
Interventions 3T MRI Scanning
Updated 6 times since 2017 Last updated: Jul 14, 2016 Started: May 31, 2005 Primary completion: Jun 30, 2015 Completion: Jun 30, 2015

This observational or N/A phase trial investigates Malignant Glioma and is currently completed. AHS Cancer Control Alberta leads this study, which shows 6 recorded versions since 2005 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. Jan 2021 — Jul 2024 [monthly]

    Completed

  4. Jun 2018 — Jan 2021 [monthly]

    Completed

  5. Apr 2018 — Jun 2018 [monthly]

    Completed

    Phase: NA → None

▶ Show 1 earlier version

  1. Jan 2017 — Apr 2018 [monthly]

    Completed NA

    First recorded

May 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • AHS Cancer Control Alberta
Data source: AHS Cancer Control Alberta

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Edmonton, Canada